---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-115270"
form_type: "8-K"
ticker: null
cik: "0000850261"
company_name: "Sorrento Therapeutics, Inc."
filed_at: "2023-11-07T23:59:59+00:00"
generated_at: "2026-06-08T18:28:13.632988+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CFO Elizabeth Czerepak terminated; Sorrento cuts US workforce from 123 to 90

## Summary
- On Nov 3, 2023, Sorrento terminated Elizabeth Czerepak as EVP and CFO, effective immediately.
- US headcount reduced from 123 to 90 employees, a 27% cut.
- No replacement CFO has been announced; CRO Mohsin Meghji signed the filing.

## SEC filing metadata
- accession: 0001104659-23-115270
- form_type: 8-K
- cik: 0000850261
- company_name: Sorrento Therapeutics, Inc.
- filed_at: 2023-11-07T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/850261/000110465923115270/0001104659-23-115270-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/850261/000110465923115270/tm2330125d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-115270
- JSON: https://secwatch.observer/filing/0001104659-23-115270.json
- Plain text: https://secwatch.observer/filing/0001104659-23-115270.txt

## Key facts
- Executive change
  Elizabeth Czerepak was terminated as Executive Vice President and Chief Financial Officer at Sorrento Therapeutics, Inc..
  - Action: terminated
  - Role: Executive Vice President and Chief Financial Officer
  source text: On November 3, 2023, in connection with the reduction in headcount described below, Sorrento Therapeutics, Inc. (“ Sorrento ” or the “ Company ”) terminated the employment of Elizabeth Czerepak as its Executive Vice President and Chief Financial Officer effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/850261/000110465923115270/0001104659-23-115270-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
